exemestane tablets ip 25 mg

25 mg Exemestane Tablets IP Exemcare—Hormonal Therapy for Breast Cancer for USA Pharma Buyers Exemcare 25 – Breast Cancer Management with Hormonal Therapy Medicines that work on hormones that can encourage the growth of some cancer cells are often used to treat breast cancer. Exemcare 25 Tablet is a medicine that belongs to a group of medicines called steroidal aromatase inhibitors. Exemestane is used to treat certain types of hormone-receptor positive breast cancer in women who are post-menopausal. It works by reducing the production of estrogen and may help slow the growth of estrogen-dependent breast cancer cells. Professional pharmaceutical trade inquiry regarding Exemcare 25 from Ernest IMPEX LLP: indications, product name, documents, and purchase requirements Product availability and eligibility of regulatory authorities Why Exemestane 25 mg Plays a Role in Breast Cancer Treatment Estrogen fuels some breast cancers. Even after enopause, the body continues to make small amounts of estrogen by converting androgens to estrogens. Aromatase is the enzyme that does this process. Exemestane inhibits aromatase activity and helps to lower circulating estrogen levels in postmenopausal women. This makes it an important hormonal treatment option for selected patients with estrogen receptor-positive breast cancer. How Exemestane Works in the Body? It inhibits the enzyme aromatase, which is involved in the conversion of androgen hormones into estrogen. Decreasing levels of estrogen can slow or suppress the growth of estrogen-dependent breast cancer cells. Exemestane is an endocrine therapy because it targets hormone production as its main action, while chemotherapy medicines target rapidly dividing cells. Tablets, Exemestane 25 mg Key Benefits: 1. Hormone Receptor Positive Breast Cancer Rationale Approved Indication/Individual Treatment Plan Exemestane is indicated in selected postmenopausal women with hormone receptor-positive breast cancer. 2. Stops Estrogen Production Exemestane is an aromatase inhibitor that inhibits production of estrogen and may decrease stimulation of hormone-sensitive cancer cells by hormones. 3. Adjunct Support with Hormone Therapy Exemestane is an approved treatment for post-menopausal patients with selected early breast cancers after they have received initial therapy with tamoxifen as part of their adjuvant therapy. 4. Treatment Option in Advanced Breast Cancer Exemestane may be used in selected postmenopausal patients with advanced breast cancer whose disease has progressed following appropriate prior endocrine treatment. 5. Oral Tablet Formulation The 25 mg oral tablet provides a defined formulation for clinician-directed endocrine therapy. The Importance of Exemcare 25 in Oncology Care Hormone receptor-positive breast cancer represents a major clinical category in which endocrine treatment may play an important role. For eligible postmenopausal patients, aromatase inhibitors provide a way to reduce estrogen exposure without directly blocking estrogen receptors. Exemestane is particularly notable because it is a steroidal, irreversible aromatase inhibitor, distinguishing it pharmacologically from nonsteroidal aromatase inhibitors such as anastrozole and letrozole. The quality of the product and the storage and handling requirements are important. Store Exemcare 25 mg tablets in the original manufacturer’s packaging at the conditions mentioned. Healthcare distributors should check the integrity of the product, the traceability of the batch, the expiry dates, and any handling instructions relevant to the product prior to acceptance or supply of stock. Professional Documentation of Pharmaceutical Buyers Depending upon the product, manufacturer, and commercial transaction, supporting documentation may include a commercial invoice, packing list, batch information, Certificate of Analysis where available, Certificate of Origin where applicable, and shipping documentation. Frequently Asked Questions 1. What is the Exemcare 25 mg Tablet? Exemcare 25 is an oral tablet containing Exemestane 25 mg, a steroidal aromatase inhibitor, for use in the treatment of certain breast cancer regimens. 2. What is the composition of Exemcare 25? The stated composition is Exemestane Tablets IP 25 mg. 3. What is Exemestane? Exemestane is a steroidal aromatase inhibitor that falls within the antineoplastic and endocrine therapy classes. 4. How does Exemestane work as a breast cancer treatment? It reduces estrogen production and helps to limit the hormonal stimulation of estrogen-dependent breast cancer cells. 5. Is exemestane a cancer medicine? Exemestane is generally classified as an endocrine or hormonal therapy rather than conventional cytotoxic chemotherapy.